Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients

Sponsor ID

20010239

Clinicaltrials.gov ID

NCT00042432

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

This study will assess an investigational medication for patients with chronic renal insufficiency (pre-dialysis) who have secondary hyperparathyroidism.

Additional Study Details

Phase

Phase 2

Product

cinacalcet hcl

Type

Interventional

Masking

Triple (Participant, Care Provider, Investigator)

Enrollment

Additional Study Details

Protocol Summary

Primary Outcome Measures

Reduction in Mean iPTH of ≥ 30% During the Efficacy Assessment Phase

Timeframe: Efficacy assessment phase (weeks 12-18)

Secondary Outcome Measures

Percentage Change from Baseline in Mean iPTH During the Efficacy Assessment Phase

Timeframe: Baseline, efficacy assessment phase (weeks 12-18)

Study Documents

Study Synopsis

Available Language(s): English

Download Document(s)

Locations

No locations found.